Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Something Old, New, Borrowed, Blue: Anthracenedione Agents for Treatment of Multiple Sclerosis.
Current and emerging therapies in multiple sclerosis: a systematic review.
Development of protein biomarkers in cerebrospinal fluid for secondary progressive multiple sclerosis using selected reaction monitoring mass spectrometry (SRM-MS).
Pathogenesis of multiple sclerosis: what can we learn from the cuprizone model.
SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease.
[Contrast agents in MRI-diagnosis of multiple sclerosis].
Effects of vitamin D on retinal nerve fiber layer in vitamin D deficient patients with optic neuritis: Preliminary findings of a randomized, placebo-controlled trial.
Comparison of the 2010 and 2005 versions of the McDonald MRI criteria for dissemination-in-time in Taiwanese patients with classic multiple sclerosis.
Novel insights into the development and maintenance of the blood-brain barrier.
Structure-activity relationship study, target identification, and pharmacological characterization of a small molecular IL-12/23 inhibitor, APY0201.
Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients.
Progressive multifocal leukoencephalopathy associated to natalizumab extended dosing regimen.
Time-Domain and Spectral-Domain Optical Coherence Tomography of Retinal Nerve Fiber Layer in MS Patients and Healthy Controls.
[Understanding needs of people with Multiple Sclerosis. Perspective of patients and significant others in the German-speaking part of Switzerland].
Epileptic seizures in Japanese patients with multiple sclerosis and neuromyelitis optica.
Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis; From the Safety Assessment of Biologic ThERapy (SABER) Study.
Vestibular-evoked myogenic potentials, clinical evaluation, and imaging findings in multiple sclerosis.
Neurological deficits caused by tissue hypoxia in neuroinflammatory disease.
Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand.
Evoked potentials in multiple sclerosis.
Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
Seizure Drug May Help in MS Eye Disease
Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis.
Erratum to: Genomic Binding Sites and Biological Effects of the Vitamin D-VDR Complex in Multiple Sclerosis.
Statins as immunomodulators: comparison with interferon-beta 1b in MS.

Pages